Ugo Consoli
Catania, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Successful Treatment of Evans Syndrome Onset With Zanubrutinib in Combination With Romiplostim During Venetoclax Treatment in a Patient With Chronic Lymphocytic Leukemia: A Case Report.
Journal: Clinical case reports
Published: January 08, 2026
Real-world experiences with subcutaneous therapy in adults with primary immune thrombocytopenia: A dual cross-sectional survey study of patients and clinicians in Italy.
Journal: Therapeutic advances in hematology
Published: December 24, 2025
Long-Term Survival with Daratumumab, Lenalidomide and Dexamethasone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients-A Survey from Two Italian Centers.
Journal: Diseases (Basel, Switzerland)
Published: December 17, 2025
Real-world efficacy and safety of fostamatinib in ITP patients: Italian multicentre experience. GIMEMA ITP1122 study.
Journal: British journal of haematology
Published: March 31, 2025
Clinician's knowledge and awareness of patient-reported outcomes in immune thrombocytopenia: Results of a national survey (ITP NET, GIMEMA Working Group Anemia and Thrombocytopenia).
Journal: Journal of public health research
Published: February 12, 2025
A real-life study of daratumumab combinations in newly diagnosed patients with light chain (AL) amyloidosis.
Journal: Hematological oncology
Published: March 11, 2024
Gaucher disease prevalence in 600 patients affected by monoclonal gammopathy of undetermined significance.
Journal: European journal of haematology
Published: June 19, 2023
Two Refractory Immune Thrombocytopenia Case Reports Showing Responsiveness to Fostamatinib.
Journal: Case reports in hematology
Published: January 16, 2023
Mucorales/Fusarium Mixed Infection in Hematologic Patient with COVID-19 Complications: An Unfortunate Combination.
Journal: Pathogens (Basel, Switzerland)
Published: January 10, 2023
Nationwide Survey on the Use of Thrombopoietin Receptor Agonists (TPO-RA) for the Management of Immune Thrombocytopenia in Current Clinical Practice in Italy.
Journal: Mediterranean journal of hematology and infectious diseases
Published: December 22, 2022
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials.
Journal: Hematological oncology
Published: February 23, 2022
Immune Thrombotic Thrombocytopenic Purpura following Pfizer-BioNTech anti-COVID-19 vaccination in a patient healed from lymphoma after allogeneic hematopoietic stem cell transplantation.
Journal: Thrombosis research
Published: October 06, 2021
Last Updated: 09/26/2026